Knowledge Item: CA-Medical Outcomes-11
Maximum Degree of Improved Quality of Life as a Function of the Type of Medical Project Providing Treatment

This Knowledge Item is a follow-up to Knowledge Item: CA-Quality of Life-50 and Knowledge Item: CA-Quality of Life-51 which also present data on the days that quality of life is maintained for  a third group of projects, Community Based Organizations, that provide psychosocial services with linkages to medical care. This Knowledge Item follows up on the earlier work by explicitly controlling for the clients stage of HIV disease, as measured by a control factor of the earliest known CD4 count, and the classification of factor as to whether the client had an AIDS-defining condition during the course of the treatment episode. Since the CBO projects did not collect data on medical test results or opportunistic infections, their data is not used here. The data from one project (with 38 patients) were not included in these analyses because that project explicitly targeted AIDS patients at the end of their lives by providing home healthcare under a managed care model, and it was believed that the data from that project would skew the results for the Managed Care projects.

The maximum change in quality of life over the course of the treatment episode was estimated and is related to a number of factors, including most importantly the relative ability of two kinds of services–managed medical care as opposed to comprehensive medical care including "wrap-around" social services–to improve the overall quality of life of their patients. The Comprehensive Medical Care providers had patients who obtained the greatest increase in quality of life over the treatment episode. These results statistically control for the initial baseline level of quality of life, differences due to psychosocial and behavioral comorbidities, differences due to medical condition near intake, and  other patient characteristics. 

On average, the patients in the University-based Comprehensive Healthcare projects had an average increase of 19%, and the patients in the Managed Care projects had an increase of 6%. Minor variations in these estimates are shown in the Additional Statistics section of this Knowledge Item; the different estimates are based on controlling different factors including patient demographics, time in program, time between assessments, initial quality of life level, and other behaviors and vulnerabilities. These results specifically correct for the medical health of the patients (as assessed by CD4 classifications) near the time of enrollment at the different projects.

Further analyses given in Knowledge Items: CA-Quality of Life and Health-37, -42, -43, -50, -51, and -39, as well as Knowledge Items: CA-Medical Outcomes-12 and -13 show additional analyses that confirm that the projects with wrap-around comprehensive psychosocial services, supplementing basic medical services, tend to maintain the patient at the same or an increased quality of life for a longer time, and with a greater ratio of improvement, than just medical services. The additional Knowledge Items use alternate statistical designs and models with different factors "controlled," but the different methods of assessing the relative effectiveness of these different types of service models in achieving improved quality of life for the patients all point out the importance of integrated psychosocial or "wrap-around" services. 

Note: The Maximum QOL Improvement Ratio is the highest quality of life score recorded during the patient's treatment episode divided by the baseline quality of life score multiplied by 100. A ratio above 100 indicates improvement at least one time after the baseline measurement while a ratio below 100 indicates that the patient declined after the baseline measurement. Means presented above are adjusted for when, during the treatment episode, the first and last assessments occurred.


More Information:     CHAID and CHAID Diagram

In interpreting this Knowledge Item, and all others in this section on Medical Outcomes, remember that the ratings of quality of life, symptom impact, and healthcare utilization are based on patient self reports unless noted otherwise. 

Knowledge Item Citation: Huba, G. J., Melchior, L. A., Panter, A. T., and the HRSA/HAB SPNS Cooperative Agreement Steering Committee (1998-2001). Knowledge Item: CA-Medical Outcomes-11 from HRSA/HAB's SPNS Cooperative Agreements on Innovative Models of Care, The Measurement Group Knowledge Base on HIV/AIDS Care, Online at www.TheMeasurementGroup.com.

Last Updated: March 25, 2005; data through June 15, 1999; analyses conducted March - November 2000.



Knowledge Base Citation: The Knowledge Base and this Knowledge Item were designed and authored by G. J. Huba, Ph.D.; in collaboration with Lisa A. Melchior, Ph.D.; A. T. Panter, Ph.D.; and the staff of The Measurement Group. Cite this work as "Huba, G. J., Melchior, L. A., and Panter, A. T. (1998 - 2001). The Measurement Group Knowledge Base on HIV/AIDS Care. On the World Wide Web: http://www.TheMeasurementGroup.com."

Questions or Comments: Contact The Measurement Group.

Use of Knowledge Base Information: Acceptable Uses and Limitations.

Collaborators from Participating Projects: Cooperative Agreement Steering Committee 1999

Participating Projects: This Knowledge Base is based on the service delivery experiences of 27 Cooperative Agreement Projects on Innovative Models of HIV/AIDS Care. These projects and the Evaluation and Dissemination Center which produced this Knowledge Base were funded by the Health Resources and Services Administration (HRSA), HIV/AIDS Bureau (HAB) as Special Projects of National Significance (SPNS) between 1994 and 1999. Click the Model Programs button above for descriptions of the projects that contributed to this specific Knowledge Item, a list of key staff, and project grant numbers.

Why This Evaluation was Conducted: Editorial.

More Information: Design of this Knowledge Base.

Recommended Citation Format for Web Materials: American Psychological Association Publication Manual Section, Revised 2001.

Work on the Knowledge Base and the cross-cutting evaluation was supported in part by Grant Number 5 U90 HA 00030-05 from the Health Resources and Services Administration (HRSA), HIV/AIDS Bureau's (HAB) Special Projects of National Significance (SPNS). The contents of this Knowledge Base are solely the responsibility of The Measurement Group and do not necessarily represent the official views of HRSA or HRSA/HAB's Special Projects of National Significance nor may they represent the positions of the individual grantees whose projects are included in the cross-cutting evaluation.



© Copyright 2005 by The Measurement Group LLC. All rights reserved.